| Prev Close | 4.56 |
| Open | 4.47 |
| Day Low/High | 4.21 / 4.68 |
| 52 Wk Low/High | 2.35 / 7.31 |
| Volume | 766.34K |
| Avg Volume | 900.60K |
Ocular Therapeutix Inc. (OCUL)
4.50
0.07
1.40
NASDAQ : Health Technology
| Exchange | NASDAQ |
| Shares Outstanding | 42.84M |
| Market Cap | 208.19M |
| EPS | -1.60 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
A Summer Friday Has Me Hunting for New Stock Ideas
The important thing to remember on days like this is to not read too much into the action.
Three to Watch in Biotech
Other than the Dow, most of major market indices are showing small gains heading into the last hour of trading. The biotech sector has not participated in today's rally and is down some 0.75% on the day so far. I am watching a few small biotech and ...
Markets Recovering From Latest Trump Tweetstorm
Wall Street discounting talk of bombing Syria from president.
Biotechs Take the Lead This Morning
Whether this market continues to bounce is going to depend a great degree on the FAANG names.
Dip Buyers Are Losing Their Confidence -- And They Have No Interest in Facebook
The longer the stock market goes without a better bounce, the bigger the risk.
You Trading Small-Cap Stocks? You Should Be
Right now this is a market for stock pickers and not timers.
Mid-Afternoon Update
2:15 pm update Markets are pretty much where they were 90 minutes ago. The S&P has strengthened a bit and overall equities have held up better than I thought given the potential partial government shutdown this weekend. We will see if stocks hold th...
These Stocks Are Changing Directions
Bullish and bearish reversals in the market.
3 Small Biotechs on the FDA Summer Calendar
Dynavax Technologies, Ocular Therapeutix and Neos Therapeutics have big drug approval dates ahead.
Keep Biotech Trigger Fingers Holstered
Three names show how fast biotechs can become oversold when the market acts in knee-jerk fashion.
Scanning the Mid-Morning Landscape
The market and 10-year Treasury yield are taking disappointing first-quarter GDP number in stride. The Chicago PMI came in stronger than expected and growth should rebound in the second quarter. Consumer spending was weak in first quarter, especiall...
3 Small Biotechs With Insider Buying
Insiders have an edge in this complex sector, so it's worth checking them out.
